Hutchinson Thomas 13D and 13G filings for Coeptis Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-09-19 5:21 pm Purchase |
2022-09-09 | 13G | Coeptis Therapeutics, Inc. COEP |
Hutchinson Thomas | 123,236 6.300% |
123,236 (New Position) |
Filing |